Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T18:22:53.890Z.
Calculation as of: 2026-10-06T18:22:53.890Z.
Quote observation: 2026-10-06T18:20:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 69957a8c264286ff6eaa706b48c8270e863bf40c8b9bfd4321b5f2d082882a11
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Sionna Therapeutics, Inc.
Market Cap
$205.89M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$204.76M
EV/EBITDA Ratio
N/A
TTM Avg
5.75x
3Y Avg
5.75x
5Y Avg
5.75x
Market Cap
$206.66M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$207.99M
EV/EBITDA Ratio
15.15x
TTM Avg
13.21x
3Y Avg
12.70x
5Y Avg
13.38x
Market Cap
$208.94M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$209.77M
EV/EBITDA Ratio
N/A
TTM Avg
14.91x
3Y Avg
15.90x
5Y Avg
15.90x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | $205.89M | N/A | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $204.76M | N/A | 5.75x | 5.75x | 5.75x |
| Whitehawk Therapeutics Inc (WHWK)vs › | $206.66M | N/A | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $207.99M | 15.15x | 13.21x | 12.70x | 13.38x |
| Alector, Inc. (ALEC)vs › | $202.62M | N/A | 16.55x | 16.55x | 16.55x |
| Exagen Inc. (XGN)vs › | $202.94M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $208.94M | N/A | N/A | N/A | N/A |
| Entrada Therapeutics, Inc. (TRDA)vs › | $209.77M | N/A | 14.91x | 15.90x | 15.90x |
| Compugen Ltd. (CGEN)vs › | $211.71M | N/A | 6.24x | 9.83x | 9.83x |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.64M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
